Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1994
10/19/1994EP0619741A1 Polar lipid composition of plant origin
10/19/1994EP0471701B1 Novel tnf-inhibit proteins and their preparation
10/19/1994CN1093705A 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1, 3-oxathiolanes; and 2,5-diaryl-1, 3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or..........
10/19/1994CN1093701A Antiretroviral hydrazine derivatives
10/19/1994CN1093596A Marrow oral liquor
10/18/1994US5356923 1-hydroxy-4(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone and anti-hypertensive use thereof
10/18/1994US5356921 Imidazolylphenol compounds, pharmaceutical compositions containing them, and processes for preparing such compounds and compositions
10/18/1994US5356909 Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
10/18/1994US5356897 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
10/18/1994US5356620 Aqueous solution containing polyvinylpyrrolidone, base, surfactant, preservative; topical treatment of allergic conjunctivitis or rhinitis
10/18/1994CA1332604C Carbocyclic compounds
10/18/1994CA1332566C Agent containing aminobenzoic acid derivative as an active ingredient having an activity to reduce side effects induced by an administration of immuno-suppressant
10/17/1994CA2121321A1 1h-indole-3-acetic acid hydrazide spla2 inhibitors
10/13/1994WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II
10/13/1994WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994WO1994022909A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
10/13/1994WO1994022863A1 Second messenger cell signaling inhibitors
10/13/1994WO1994022852A1 Quinolines as type iv phosphodiesterase inhibitors
10/13/1994WO1994022814A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
10/13/1994WO1994022475A1 Cloned leptospira outer membrane protein
10/13/1994WO1994022462A1 Anti-aids immunomodulator complex
10/13/1994WO1994022459A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic
10/13/1994WO1994022448A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
10/13/1994WO1994022441A2 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
10/13/1994WO1994021240A3 Superparamagnetic particles, process for producing the same and their use
10/13/1994CA2159506A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994CA2159447A1 Use of cis-or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
10/13/1994CA2159359A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic
10/13/1994CA2159072A1 Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors
10/13/1994CA2158540A1 Cloned leptospira outer membrane protein
10/13/1994CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii
10/12/1994EP0619296A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
10/12/1994EP0619117A2 Use of acemannan
10/12/1994EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
10/12/1994EP0618907A1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents
10/12/1994EP0618898A1 Amidino derivatives and their use as nitric oxide synthase inhibitors
10/12/1994EP0618889A1 Tri-substituted phenyl derivatives and processes for their preparation
10/12/1994CN1093363A Substituted pyrazoles
10/11/1994US5354848 Producing simple or substituted carbamylic amino groups, or substituted thiocarbamylic amino groups or substituted guanidino groups; hyposensitizing therapy
10/11/1994US5354781 Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
10/11/1994US5354776 Treating psoriasis
10/11/1994US5354745 Estradiol derivative-chlorambucil conjugate process for preparing the same, and pharmaceutical composition
10/11/1994US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
10/05/1994EP0618220A1 Method for purifying interleukin-4
10/05/1994EP0618206A1 Pharmaceutical compounds
10/05/1994EP0617959A1 Pharmaceutical for the treatment of skin disorders
10/05/1994EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
10/05/1994EP0482100B1 Novel vitamin d analogues
10/05/1994EP0436690B1 Extracts of the acanthospermum hispidum plant
10/04/1994US5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
10/04/1994US5352701 Leukotriene-B4 antagonist compounds and their use as pharmaceutical agents
10/04/1994US5352694 Pharmaceutical agents
10/04/1994US5352690 For asthma, allergies
10/04/1994US5352676 Morphalinomethyl-substituted 1-phenyl-indero-[1,2-c]pyrazol-3-yl derivatives of 2-cyano-3-oxo-propanamides useful in the treatment of rheumatoid arthritis
10/04/1994US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
10/04/1994US5352462 Presents in whey of pasteurized skimmed milk both in aggregate and nonaggregate form, free of peptide or protein, binds to chromatography medium, not inactivated by boiling
10/04/1994CA1332238C 4h-1-benzopyran-4-one derivatives, a process for their preparation and their use as medicaments
10/04/1994CA1332222C Pharmaceutical composition for preventing and treating diseases caused by primary immune deficiences
09/1994
09/29/1994WO1994021808A1 Process for preparing cancer vaccines
09/29/1994WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES
09/29/1994WO1994021798A1 Stimulation of immune response by viral protein
09/29/1994WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
09/29/1994WO1994021675A2 T cell epitopes of ryegrass pollen allergen
09/29/1994WO1994021644A1 Thio-heterocyclic macrolactam immunomodulators
09/29/1994WO1994021643A1 Macrocyclic carbamate immunomodulators
09/29/1994WO1994021642A1 Macrocyclic amide and urea immunomodulators
09/29/1994WO1994021625A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
09/29/1994WO1994021616A1 Heterocycle-containing amidine derivatives, their preparation and use
09/29/1994WO1994021604A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use
09/29/1994WO1994021292A1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
09/29/1994WO1994021288A1 Composition and method for reducing toxicity of biologically-active factors
09/29/1994WO1994021275A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
09/29/1994WO1994021269A1 Drugs for the treatment of retrovirus infections
09/29/1994WO1994021261A1 Use of triazine compounds as anxiolytics
09/29/1994WO1994021258A1 Heterocycle-containing macrocyclic immunomodulators
09/29/1994WO1994021254A1 Substituted alicyclic amine-containing macrocyclic immunomodulators
09/29/1994WO1994021247A1 Use of cis-9-heptadecenoic acid for treating psoriasis, allergies and autoimmune diseases
09/29/1994WO1994021240A2 Superparamagnetic particles, process for producing the same and their use
09/29/1994WO1994021235A1 Enhanced circulation effector composition and method
09/29/1994WO1994016094A3 Recombinant anti-vla4 antibody molecules
09/29/1994WO1994015958A3 Peptide inhibitors of cell adhesion
09/29/1994WO1994014833A3 Substituted 6-azaandrostenones
09/29/1994WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/29/1994CA2158994A1 Heterocycle-containing amidine derivatives, their preparation and use
09/29/1994CA2158655A1 Process for preparing cancer vaccines
09/29/1994CA2158551A1 Drugs for the treatment of retrovirus infections
09/29/1994CA2158461A1 Stimulation of immune response by viral protein
09/29/1994CA2158352A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
09/29/1994CA2157758A1 Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine
09/29/1994CA2157596A1 T cell epitopes of ryegrass pollen allergen
09/29/1994CA2156068A1 Macrocyclic carbamate immunomodulators
09/29/1994CA2156067A1 Heterocycle-containing macrocyclic immunomodulators
09/29/1994CA2156065A1 Macrocyclic amide and urea immunomodulators
09/29/1994CA2156064A1 Substituted alicyclic amine-containing macrocyclic immunomodulators
09/28/1994EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins
09/28/1994EP0617126A2 Polypeptide capable of inhibiting the binding bewteen human IL-6 and its receptor
09/28/1994EP0617032A1 Cyanomethylpyridine derivatives as PAF antagonists and 5-lipoxygenase inhibitors
09/28/1994EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes
09/28/1994EP0617028A1 Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulfonyl piperazine
09/28/1994EP0617024A1 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof